Angioskope Brazil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Angioskope brazil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Angioskope Brazil Today - Breaking & Trending Today

Semaglutide Boosts Weight Loss Following Endoscopic Gastroplasty

Semaglutide Boosts Weight Loss Following Endoscopic Gastroplasty
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United States , Scott Kahan , Milken Institute , National Center , George Washington University , European Medicines Agency , Drug Administration , School Of Public Health , Novo Nordisk , Anna Carolina Hoff , Angioskope Brazil , Medscape Medical , Digestive Disease , Public Health , Lost Fat Mass , Excess Weight , ஒன்றுபட்டது மாநிலங்களில் , ஸ்காட் கஹான் , பால் நிறுவனம் , தேசிய மையம் , ஜார்ஜ் வாஷிங்டன் பல்கலைக்கழகம் , பள்ளி ஆஃப் பொது ஆரோக்கியம் , செரிமான நோய் , பொது ஆரோக்கியம் , அதிகப்படியான எடை ,

Pairing bariatric procedure with diabetes drug increases weight loss

E-Mail
Bethesda, MD (May 14, 2021) Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was selected for presentation at Digestive Disease Week® (DDW) 2021.
As the worldwide obesity rate continues to climb, so do the number of people seeking bariatric surgery to treat their condition, said Anna Carolina Hoff, MD, lead researcher on the study and founder and clinical director of Angioskope Brazil, São José dos Campos. Surgical procedures are some of the most successful ways to help patients lose weight, but they can eventually come with complications. Our study shows that patients may not have to undergo invasive surgery to get similar results. ....

United States , American Society For Gastrointestinal Endoscopy , Society For Surgery Of The Alimentary Tract , American Gastroenterological Association , Digestive Disease Week , Anna Carolina Hoff , Angioskope Brazil , Disease Week , American Association , Liver Diseases , American Society , Gastrointestinal Endoscopy , Alimentary Tract , Medicine Health , Diet Body Weight , Internal Medicine , ஒன்றுபட்டது மாநிலங்களில் , அமெரிக்கன் சமூகம் க்கு இரைப்பை குடல் எண்டோஸ்கோபி , சமூகம் க்கு அறுவை சிகிச்சை ஆஃப் தி அழிமேன்டரி பாதை , செரிமான நோய் வாரம் , நோய் வாரம் , அமெரிக்கன் சங்கம் , கல்லீரல் நோய்கள் , அமெரிக்கன் சமூகம் , இரைப்பை குடல் எண்டோஸ்கோபி , அழிமேன்டரி பாதை ,

Adding GLP-1 Drug Makes Sleeve Gastroplasty a Diabetes Treatment

This article is a collaboration between MedPage Today and:
A key limitation of endoscopic sleeve gastroplasty (ESG) might be overcome by adding a diabetes drug to follow-up care, a small sham-controlled trial from Brazil suggested.
Patients who took semaglutide (Ozempic) following ESG showed significantly greater losses of body fat and lower HbA1c levels compared with those who had only usual care after the procedures, said Anna Carolina Hoff, MD, of Angioskope Brazil in São José dos Campos, during a press briefing held in advance of the annual Digestive Disease Week meeting.
With 58 patients evaluable, body fat mass losses at the 1-year follow-up after ESG averaged 9.0 percentage points in the usual care group versus 12.7 with add-on semaglutide ( ....

Medpage Today , Anna Carolina Hoff , Angioskope Brazil , Digestive Disease Week , செரிமான நோய் வாரம் ,